Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Reposting for new investors GLA
Reposting for new investors
Good Luck Genuine Bravehearters
Reposting for new investors GLA
Reposting for new investors GLA
Reposting for new investors GLA
Reposting for new investors GLA
Reposting for new investors GLA
Reposting for new investors GLA
Reposting for new investors GLA
Reposting for new investors GLA
Reposting for new investors GLA
Reposting for new investors GLA
Reposting for new investors GLA
Reposting for new investors GLA
Reposting for new investors GLA
Reposting for new investors GLA
.
Reposting for new investors GLA
Paraytec’s test is rapid, portable, reusable and does not require trained staff to operate it can be multiplexed which approx. 100 tests can be performed in a very short time. There are existing Worldwide patents in place and more applied for. The plan is for worldwide sales in every country. Think of all the lives that will be saved!
I know of two friends that died of Sepsis, one just after she gave birth. It is a horrible insidious disease.
Our device may possibly be an all test in one! I do not know how they plan on develop it and whether the software onboard the device will enable all tests. It may well be that the hardware of the device is the same as for a covid-19 test as per the same for a Sepsis test but with different software in which case you are able to double the number of units sold to the world-wide health centres. Then there is the Bladder Cancer test using the same device but adapted to test urine for cancer cells shredded by a tumour in the bladder.
This is being spun out in a new company called Sentinel in which we own 33% of the company so I can see a sale of our stake in Sentinel resulting in a very large SPECIAL DIVIDEND FOR ALL EXISTING SHARE HOLDERS IN BRAVEHEART! The future is very bright!
I would imagine there will be separate models for each clinical need.
Link to Antibiotic Research UK
https://www.antibioticresearch.org.uk/about-antibiotic-resistance/bacterial-infections/sepsis/?gclid=Cj0KCQjwvYSEBhDjARIsAJMn0ljeKyBGkpkgzMEyMq_mWpaqWmFOfnEDARJ4fNjyOM2Uxw88VF99urMaAhmcEALw_wcB
Braveheart’s 100% owned sub company Paraytec have identified an area of unmet medical need in the detection of Sepsis. Approx. 50 million people every year suffer from Sepsis and approx. 11 million people die from the it. Sepsis is a life-threatening organ disfunction which needs to receive anti-microbial therapy in the first hour for a good outcome, but for every hour that you go undiagnosed and not treated death is more likely. There are approx. 50 different micro-organisms such as bacteria and viruses that cause Sepsis. For treatment one needs to identify the bacteria or virus that is causing the Sepsis. Paraytec can test for all 50 micro-organisms in a matter of minutes which will save thousands if not millions of lives worldwide in early diagnosis of Sepsis but more importantly the actual one of FIFTY DIFFERENT BIOLOGICAL OR VIRUSES that are causing the Sepsis which then appropriate treatment can be administered.
See link below and at 12:58 minutes into the interview Professor Carl Smythe informs of our Rapid Sepsis Test which will be a modification to our rapid Covid-19 test I assume.
https://www.proactiveinvestors.co.uk/companies/news/943228/paraytec-lead-covid-19-professor-on-sensitivity-and-specificity-of-various-types-of-covid-19-tests-943228.html